# CHAMPION-AF Clinical Trial

Study · id `cardio:ct-nct04394546` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04394546](<https://clinicaltrials.gov/study/NCT04394546>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04394546

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 3000 participants.

## Technical summary

Registry record NCT04394546. Randomized; single masking; primary purpose prevention. Start 2020-10-15 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 3000 participants (enrolled count; ClinicalTrials.gov record NCT04394546, source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)
- Started: 2020-10-15 (actual) (ClinicalTrials.gov record NCT04394546, source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT04394546, source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT04394546, source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)
- Countries: United States; Australia; Belgium; Canada; Denmark; France; Germany; Israel; Italy; Japan; Netherlands; Poland; Saudi Arabia; Spain; Switzerland; United Kingdom (ClinicalTrials.gov record NCT04394546, source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04394546-2026-11-16`, retrieved 2026-11-18)

## The registry's words

- Brief title: CHAMPION-AF Clinical Trial
- Acronym: CHAMPION-AF
- Condition: Atrial Fibrillation
- Condition: Stroke
- Condition: Bleeding
- Intervention (Device): WATCHMAN FLX LAAC Device
- Intervention (Drug): Non-Vitamin K Oral Anticoagulant
- Lead sponsor: Boston Scientific Corporation
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: c36328544e761d587505c8946e2306d5192e38242b348c7563b4db7e0185a352
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
